Clinical Trial

A Clinical Trial of Longqi Jiangzhi Decoction Against Non-alcoholic Fatty Liver Disease

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated January 6, 2026 (before its estimated May 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to learn if Longqi Jiangzhi decoction works to treat non-alcoholic fatty liver disease in adults. It will also learn about the safety of drug Longqi Jiangzhi decoction. Researchers will compare drug Longqi Jiangzhi decoction to a placebo (a look-alike substance that contains no drug) to see if drug Longqi Jiangzhi decoction works to treat non-alcoholic fatty liver disease. Participants will: Take drug Longqi Jiangzhi decoction or a placebo every day for eight weeks Keep a record of their symptoms and the degree of hepatic steatosis before and after the treatment.
Trial Details
NCT Number NCT07320456
Lead Sponsor Shanghai Municipal Hospital of Traditional Chinese Medicine
Conditions Hepatic Steatosis
Enrollment 80 participants
Start Date 2025-12-29
Primary Completion 2026-05-31 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-06